Goldman sees earnings upside for these 2 IT Services stocks
Get Alerts IBM Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 2.6%
EPS Growth %: +7.9%
Join SI Premium – FREE
Investing.com -- In a note to clients on Friday, Goldman Sachs flagged modest earnings upside for IBM (NYSE: IBM) and Cognizant (NASDAQ: CTSH) heading into first-quarter results, while warning that Globant faces downside risk from its exposure to pressured verticals and the Middle East conflict.
Analyst James Schneider stated in a note that the setup for the IT services sector appears "increasingly undemanding" following a material de-rating driven by persistent AI-disruption concerns, creating the conditions for selective outperformance on solid prints.
On IBM, which Goldman rates buy, Schneider said software momentum is likely intact despite an anticipated slowdown in mainframe growth.
"We view IBM as relatively resilient to broader AI-driven concerns in software, supported by continued strength in its core portfolio," he wrote.
For Cognizant, rated neutral, Goldman said results should be supported by stable execution, a strong backlog of large deals and positive commentary around AI adoption and productivity gains.
"Given low expectations, we see potential for near-term stock outperformance on a solid print," Schneider wrote, though he noted the firm remains more cautious longer-term given persistent gross margin headwinds.
Globant, also rated neutral, is seen facing the most pressure, with Goldman flagging outsized exposure to Media and Entertainment as well as significant business in the Middle East.
While positive AI demand commentary around the company's "AI Pods" offering is expected, Schneider said he does not expect it to offset near-term growth headwinds from softer discretionary spending.
Goldman said investor focus this quarter will center on demand commentary given rising macro uncertainty, with AI adoption updates likely to be a key area of attention.
You May Also Be Interested In
- Nvidia pitches Vera CPU to Chinese clients with August delivery target
- PreveCeutical closes second tranche of private placement for $245,000
- These 2 things are key for Meta stock re-rating: BofA
Create E-mail Alert Related Categories
General News, InvestingRelated Entities
Goldman Sachs, Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share